Top Legislation - View All
Also tagged in: Administrative procedure, Congress, Congressional reporting requirements, Cytology, Department of Health and Human Services, Executive departments, Governmental investigations, Human embryology, Law, Medical care, Medical research, Medicine, Science policy, Standards
Latest Action: 04/16/2007 - Received in the House. Bill TextA bill to intensify research to derive human pluripotent stem cell lines. 4/11/2007--Passed Senate without amendment. (There is 1 other summary) (This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.) Hope Offered through Principled and Ethical Stem Cell Research Act or the HOPE Act - (Sec. 3) Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop techniques for the isolation, derivation, production, or testing of stem cells, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not they have an embryonic source), that may result in improved understanding of or treatments for diseases and other adverse health conditions, provided that such techniques do not involve: (1) the creation of a human embryo or embryos for research purposes; or (2) the destruction or discarding of, or [...] show full description
Also tagged in: Administrative procedure, Blood tests, Consumers, Data banks, Department of Health and Human Services, Electronic data interchange, Executive departments, Food and Drug Administration (FDA), Genetics, Government information, Government paperwork, Government publicity, Internet, Labeling, Law, Medical care, Medical instruments and apparatus, Medical laboratories, Medical supplies, Medical tests, Medicine, Standards, Technology, Telecommunication, Web sites
Latest Action: 03/01/2007 - Sponsor introductory remarks on measure. (CR S2502-2503) Bill TextA bill to provide for the regulation and oversight of laboratory tests. 3/1/2007--Introduced. Laboratory Test Improvement Act - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to deem a laboratory-developed test that is a direct-to-consumer test to be a prescription test if it satisfies the requirements of this Act. Deems any laboratory-developed test to be a medical device.Sets forth labeling and registration requirements for laboratory-developed tests.Requires the manufacturer of a laboratory-developed test that has not been cleared or approved for its intended use to submit the analytical and clinical validity of the test for its intended use to the Secretary of Health and Human Services. Requires the Secretary to include such information in a public database.Requires the Secretary to provide guidance to: (1) facilitate the use of reviews of the peer-reviewed biomedical literature and other information and data about the clinical validity [...] show full description
Also tagged in: Administrative procedure, Armed forces, Asbestos, Budgets, Business, Cancer, Clinical trials, Consumer education, Consumers, Data banks, Defense policy, Department of Health and Human Services, Environmental health, Environmental protection, Environmental Protection Agency, Environmental research, Executive departments, Federal aid to health facilities, Federal aid to research, Fibers, Government information, Government publicity, Governmental investigations, Hazardous substances, Hazardous wastes, Health education, Health information systems, Import restrictions, Labeling, Labor, Law, Lung cancer, Lung diseases, Manufacturing industries, Medical care, Medical centers, Medical research, Medical screening, Medical tests, Medicine, Military medicine, Minerals, National Institutes of Health (NIH), Occupational health and safety, Pain, Preventive medicine, Product safety, Refuse and refuse disposal, Research centers, Research grants, Science policy, Solid wastes, Technology, Trade, Veterans, Veterans' hospitals, Veterans' medical care
Latest Action: 10/05/2007 - Message on Senate action sent to the House. Bill TextAn act to amend the Toxic Substances Control Act to reduce the health risks posed by asbestos-containing materials and products having asbestos-containing material, and for other purposes. 10/4/2007--Passed Senate amended. (There is 1 other summary) Ban Asbestos in America Act of 2007 - (Sec. 3) Amends the Toxic Substances Control Act to include within the meaning of the term "asbestos" asbestiform varieties of: (1) any material formerly classified as tremolite, including winchite asbestos and richterite asbestos; and (2) any asbestiform amphibole mineral. Requires the Director of the National Institute for Occupational Safety and Health to conduct a study that: (1) describes the science concerning the disease mechanisms and health effects of exposure to non-asbestiform minerals and elongated mineral particles and methods for measuring and analyzing such minerals; and (2) recommends future research relating to diseases caused by exposure [...] show full description
Also tagged in: Administrative procedure, Authorization, Budgets, Childbirth, Cytology, Data banks, Department of Health and Human Services, Executive departments, Health information systems, Human embryology, Informed consent (Medical law), Law, Medical care, Medicine, Public contracts, Technology, Transplantation of organs, tissues, etc.
Latest Action: 03/22/2007 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill TextA bill to provide for the collection and maintenance of amniotic fluid and placental stem cells for the treatment of patients and research. 3/22/2007--Introduced. Amniotic Fluid and Placental Stem Cell Banking Act of 2007 - Directs the Secretary of Health and Human Services to enter into one-time contracts with qualified amniotic fluid and placental stem cell banks to assist in the collection and maintenance of 100,000 new units of high-quality amniotic fluid and placental stem cells to be made available for treatment though the C.W. Bill Young Cell Transplantation and Treatment Program. Sets forth provisions relating to requirements for contract recipients, the duration of such contracts, and extensions of funding under such contracts. Amends the Public Health Service Act to revise the Program to provide for amniotic fluid and placental stem cell functions, recruitment, and educational activities. Authorizes appropriations for the Program through FY2012.
Also tagged in: Access to health care, Aged, Biomedical engineering, Budgets, Cancer, Case management, Chemotherapy, Children, Clinical trials, Colon cancer, Congress, Congressional reporting requirements, Continuum of care, Department of Health and Human Services, Drug abuse, Drug approvals, Education, Environmental health, Environmental protection, Executive departments, Federal advisory bodies, Federal aid to child health services, Federal aid to health facilities, Federal aid to research, Genetic research, Governmental investigations, Health planning, Health policy, Higher education, Imaging systems in medicine, Intellectual property, Lung cancer, Medical care, Medical education, Medical instruments and apparatus, Medical research, Medical screening, Medical supplies, Medical technology, Medicare, Medicine, Minorities, Minority health, National Institutes of Health (NIH), Nursing, Patents, Pharmaceutical research, Preventive medicine, Quality of care, Quality of life, Research centers, Scholarships, Science policy, Smoking, Strategic planning, Student loan funds, Technology
Latest Action: 03/29/2007 - Sponsor introductory remarks on measure. (CR S4188) Bill TextA bill to provide for a comprehensive Federal effort relating to early detection of, treatments for, and the prevention of cancer, and for other purposes. 3/29/2007--Introduced. National Cancer Act of 2007 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to establish a loan repayment program for health professionals agreeing to engage in cancer prevention research. Provides for research on cancer treatments that target cancer cells, the cancer care workforce, cancer survivorship, environmental risk factors for cancer, and treatment disparities.Requires the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to carry out demonstration programs on: (1) lung cancer early detection using Computer Tomography (CT) scanning; and (2) colorectal screening.Amends the Federal Food, Drug, and Cosmetic Act to set forth provisions for chemoprevention [...] show full description
Also tagged in: Accreditation (Medical care), Administrative procedure, Auditing, Budgets, Criminal justice, Cytology, Department of Health and Human Services, Donation of organs, tissues, etc., Executive departments, Federal preemption, Fines (Penalties), Fraud, Government information, Government publicity, Informed consent (Medical law), Law, Medical care, Medical ethics, Medical records, Medicine, State and local government, State laws, User charges
Latest Action: 05/24/2007 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill TextA bill to improve the oversight and regulation of tissue banks and the tissue donation process, and for other purposes. 5/24/2007--Introduced. Safe Tissue Act - Requires the Food and Drug Administration (FDA) to inspect, at least once every two years, each establishment that engages in the manufacture of human cells, tissues, and cellular and tissue-based products. Allows the Secretary of Health and Human Services to establish a user fee to fund such inspections. Requires the FDA to conduct periodic audits of all documentation submitted by each such establishment to determine compliance with all applicable requirements, including requirements related to ensuring: (1) that human cells, tissues, or cellular or tissue-based products are obtained legally; (2) that donor eligibility and donor medical history interviews are based on accurate information that was not provided or obtained in a fraudulent manner; and (3) current good tissue practice. Requires the Secretary [...] show full description
Also tagged in: Accreditation (Medical care), Administrative procedure, Auditing, Budgets, Criminal justice, Cytology, Department of Health and Human Services, Donation of organs, tissues, etc., Executive departments, Federal preemption, Fines (Penalties), Fraud, Government information, Government publicity, Informed consent (Medical law), Law, Medical care, Medical ethics, Medical records, Medicine, State and local government, State laws, User charges
Latest Action: 06/14/2007 - Referred to the Subcommittee on Health. Bill TextTo improve the oversight and regulation of tissue banks and the tissue donation process, and for other purposes. 6/14/2007--Introduced. Safe Tissue Act - Requires the Food and Drug Administration (FDA) to inspect, at least once every two years, each establishment that engages in the manufacture of human cells, tissues, and cellular and tissue-based products. Allows the Secretary of Health and Human Services to establish a user fee to fund such inspections. Requires the FDA to conduct periodic audits of all documentation submitted by each such establishment to determine compliance with all applicable requirements, including requirements related to ensuring: (1) that human cells, tissues, or cellular or tissue-based products are obtained legally; (2) that donor eligibility and donor medical history interviews are based on accurate information that was not provided or obtained in a fraudulent manner; and (3) current good tissue practice. Requires the Secretary [...] show full description
Also tagged in: Animals, Budgets, California, Census, Coastal zone, Commendations, Communicable diseases, Congress, Congressional reporting requirements, Demography, Ecological research, Ecosystem management, Endangered species, Environmental education, Environmental protection, Executive departments, Federal advisory bodies, Federal aid to research, Food, Government information, Government publicity, Hazardous substances, Health planning, Health policy, Immunology, Marine ecology, Marine pollution, Marine resources, Medical care, Medical research, Medical tests, Medicine, Nutrition, Otters, Pacific Ocean, Parasitic diseases, Protection of animals, Public meetings, Research grants, Science policy, Toxicology, Veterinary medicine, Virus diseases, Water pollution
Latest Action: 04/24/2008 - Subcommittee Hearings Held. Bill TextTo establish a program of research and other activities to provide for the recovery of the southern sea otter. 9/24/2007--Introduced. Southern Sea Otter Recovery and Research Act - Requires the Secretary of the Interior, acting through the United States Fish and Wildlife Service, to carry out a recovery program for southern sea otter populations along the coast of California.Requires the Secretary to: (1) develop a Southern Sea Otter Health Assessment Plan; (2) collect and analyze tissue samples from southern sea otters; and (3) submit the tissue to the Secretary of Commerce for inclusion in the National Marine Mammal Tissue Bank to allow for managed access to such tissues by other researchers.Requires the Secretary to: (1) award competitive grants to support research regarding southern sea otters; and (2) establish and appoint the Southern Sea Otter Recovery Implementation Team to make recommendations on overall implementation of the southern sea otter recovery [...] show full description
Also tagged in: Blood banks, Blood tests, Budgets, Clinical trials, Data banks, Epidemiology, Executive departments, Federal advisory bodies, Federal aid to health facilities, Federal aid to research, Health policy, Laboratories, Medical care, Medical research, Medical screening, Medical statistics, Medical tests, Medicine, Nonprofit organizations, Ovarian cancer, Research centers, Research grants, Risk, Science policy, Social services, Technology, Urinalysis, Women, Women's health, Women's health services
Latest Action: 11/08/2007 - Referred to the Subcommittee on Health. Bill TextTo amend the Public Health Service Act to authorize the Director of the National Cancer Institute to make grants for the discovery and validation of biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. 9/27/2007--Introduced. Ovarian Cancer Biomarker Research Act of 2007 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate centers to conduct research on biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. Designates each center as an Ovarian Cancer Biomarker Center of Excellence.Allows federal payments under such an agreement or grant to be used for research on: (1) the development and characterization of new biomarkers and the refinement of existing biomarkers; (2) the clinical and laboratory validation of such [...] show full description
Also tagged in: Blood banks, Blood tests, Budgets, Clinical trials, Data banks, Epidemiology, Executive departments, Federal advisory bodies, Federal aid to health facilities, Federal aid to research, Health policy, Laboratories, Medical care, Medical research, Medical screening, Medical statistics, Medical tests, Medicine, Nonprofit organizations, Ovarian cancer, Research centers, Research grants, Risk, Science policy, Social services, Technology, Urinalysis, Women, Women's health, Women's health services
Latest Action: 01/29/2008 - Sponsor introductory remarks on measure. (CR S448) Bill TextA bill to amend the Public Health Service Act to authorize the Director of the National Cancer Institute to make grants for the discovery and validation of biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. 1/29/2008--Introduced. Ovarian Cancer Biomarker Research Act of 2008 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate centers to conduct research on biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. Designates each center as an Ovarian Cancer Biomarker Center of Excellence.Allows federal payments under such an agreement or grant to be used for research on: (1) the development and characterization of new biomarkers and the refinement of existing biomarkers; (2) the clinical and laboratory validation [...] show full description
|
Latest Legislation - View All
Also tagged in: Blood banks, Blood tests, Budgets, Clinical trials, Data banks, Epidemiology, Executive departments, Federal advisory bodies, Federal aid to health facilities, Federal aid to research, Health policy, Laboratories, Medical care, Medical research, Medical screening, Medical statistics, Medical tests, Medicine, Nonprofit organizations, Ovarian cancer, Research centers, Research grants, Risk, Science policy, Social services, Technology, Urinalysis, Women, Women's health, Women's health services
Latest Action: 01/29/2008 - Sponsor introductory remarks on measure. (CR S448) Bill TextA bill to amend the Public Health Service Act to authorize the Director of the National Cancer Institute to make grants for the discovery and validation of biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. 1/29/2008--Introduced. Ovarian Cancer Biomarker Research Act of 2008 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate centers to conduct research on biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. Designates each center as an Ovarian Cancer Biomarker Center of Excellence.Allows federal payments under such an agreement or grant to be used for research on: (1) the development and characterization of new biomarkers and the refinement of existing biomarkers; (2) the clinical and laboratory validation [...] show full description
Also tagged in: Blood banks, Blood tests, Budgets, Clinical trials, Data banks, Epidemiology, Executive departments, Federal advisory bodies, Federal aid to health facilities, Federal aid to research, Health policy, Laboratories, Medical care, Medical research, Medical screening, Medical statistics, Medical tests, Medicine, Nonprofit organizations, Ovarian cancer, Research centers, Research grants, Risk, Science policy, Social services, Technology, Urinalysis, Women, Women's health, Women's health services
Latest Action: 11/08/2007 - Referred to the Subcommittee on Health. Bill TextTo amend the Public Health Service Act to authorize the Director of the National Cancer Institute to make grants for the discovery and validation of biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. 9/27/2007--Introduced. Ovarian Cancer Biomarker Research Act of 2007 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate centers to conduct research on biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. Designates each center as an Ovarian Cancer Biomarker Center of Excellence.Allows federal payments under such an agreement or grant to be used for research on: (1) the development and characterization of new biomarkers and the refinement of existing biomarkers; (2) the clinical and laboratory validation of such [...] show full description
Also tagged in: Animals, Budgets, California, Census, Coastal zone, Commendations, Communicable diseases, Congress, Congressional reporting requirements, Demography, Ecological research, Ecosystem management, Endangered species, Environmental education, Environmental protection, Executive departments, Federal advisory bodies, Federal aid to research, Food, Government information, Government publicity, Hazardous substances, Health planning, Health policy, Immunology, Marine ecology, Marine pollution, Marine resources, Medical care, Medical research, Medical tests, Medicine, Nutrition, Otters, Pacific Ocean, Parasitic diseases, Protection of animals, Public meetings, Research grants, Science policy, Toxicology, Veterinary medicine, Virus diseases, Water pollution
Latest Action: 04/24/2008 - Subcommittee Hearings Held. Bill TextTo establish a program of research and other activities to provide for the recovery of the southern sea otter. 9/24/2007--Introduced. Southern Sea Otter Recovery and Research Act - Requires the Secretary of the Interior, acting through the United States Fish and Wildlife Service, to carry out a recovery program for southern sea otter populations along the coast of California.Requires the Secretary to: (1) develop a Southern Sea Otter Health Assessment Plan; (2) collect and analyze tissue samples from southern sea otters; and (3) submit the tissue to the Secretary of Commerce for inclusion in the National Marine Mammal Tissue Bank to allow for managed access to such tissues by other researchers.Requires the Secretary to: (1) award competitive grants to support research regarding southern sea otters; and (2) establish and appoint the Southern Sea Otter Recovery Implementation Team to make recommendations on overall implementation of the southern sea otter recovery [...] show full description
Also tagged in: Accreditation (Medical care), Administrative procedure, Auditing, Budgets, Criminal justice, Cytology, Department of Health and Human Services, Donation of organs, tissues, etc., Executive departments, Federal preemption, Fines (Penalties), Fraud, Government information, Government publicity, Informed consent (Medical law), Law, Medical care, Medical ethics, Medical records, Medicine, State and local government, State laws, User charges
Latest Action: 06/14/2007 - Referred to the Subcommittee on Health. Bill TextTo improve the oversight and regulation of tissue banks and the tissue donation process, and for other purposes. 6/14/2007--Introduced. Safe Tissue Act - Requires the Food and Drug Administration (FDA) to inspect, at least once every two years, each establishment that engages in the manufacture of human cells, tissues, and cellular and tissue-based products. Allows the Secretary of Health and Human Services to establish a user fee to fund such inspections. Requires the FDA to conduct periodic audits of all documentation submitted by each such establishment to determine compliance with all applicable requirements, including requirements related to ensuring: (1) that human cells, tissues, or cellular or tissue-based products are obtained legally; (2) that donor eligibility and donor medical history interviews are based on accurate information that was not provided or obtained in a fraudulent manner; and (3) current good tissue practice. Requires the Secretary [...] show full description
Also tagged in: Accreditation (Medical care), Administrative procedure, Auditing, Budgets, Criminal justice, Cytology, Department of Health and Human Services, Donation of organs, tissues, etc., Executive departments, Federal preemption, Fines (Penalties), Fraud, Government information, Government publicity, Informed consent (Medical law), Law, Medical care, Medical ethics, Medical records, Medicine, State and local government, State laws, User charges
Latest Action: 05/24/2007 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill TextA bill to improve the oversight and regulation of tissue banks and the tissue donation process, and for other purposes. 5/24/2007--Introduced. Safe Tissue Act - Requires the Food and Drug Administration (FDA) to inspect, at least once every two years, each establishment that engages in the manufacture of human cells, tissues, and cellular and tissue-based products. Allows the Secretary of Health and Human Services to establish a user fee to fund such inspections. Requires the FDA to conduct periodic audits of all documentation submitted by each such establishment to determine compliance with all applicable requirements, including requirements related to ensuring: (1) that human cells, tissues, or cellular or tissue-based products are obtained legally; (2) that donor eligibility and donor medical history interviews are based on accurate information that was not provided or obtained in a fraudulent manner; and (3) current good tissue practice. Requires the Secretary [...] show full description
Also tagged in: Administrative procedure, Congress, Congressional reporting requirements, Cytology, Department of Health and Human Services, Executive departments, Governmental investigations, Human embryology, Law, Medical care, Medical research, Medicine, Science policy, Standards
Latest Action: 04/16/2007 - Received in the House. Bill TextA bill to intensify research to derive human pluripotent stem cell lines. 4/11/2007--Passed Senate without amendment. (There is 1 other summary) (This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.) Hope Offered through Principled and Ethical Stem Cell Research Act or the HOPE Act - (Sec. 3) Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop techniques for the isolation, derivation, production, or testing of stem cells, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not they have an embryonic source), that may result in improved understanding of or treatments for diseases and other adverse health conditions, provided that such techniques do not involve: (1) the creation of a human embryo or embryos for research purposes; or (2) the destruction or discarding of, or [...] show full description
Also tagged in: Access to health care, Aged, Biomedical engineering, Budgets, Cancer, Case management, Chemotherapy, Children, Clinical trials, Colon cancer, Congress, Congressional reporting requirements, Continuum of care, Department of Health and Human Services, Drug abuse, Drug approvals, Education, Environmental health, Environmental protection, Executive departments, Federal advisory bodies, Federal aid to child health services, Federal aid to health facilities, Federal aid to research, Genetic research, Governmental investigations, Health planning, Health policy, Higher education, Imaging systems in medicine, Intellectual property, Lung cancer, Medical care, Medical education, Medical instruments and apparatus, Medical research, Medical screening, Medical supplies, Medical technology, Medicare, Medicine, Minorities, Minority health, National Institutes of Health (NIH), Nursing, Patents, Pharmaceutical research, Preventive medicine, Quality of care, Quality of life, Research centers, Scholarships, Science policy, Smoking, Strategic planning, Student loan funds, Technology
Latest Action: 03/29/2007 - Sponsor introductory remarks on measure. (CR S4188) Bill TextA bill to provide for a comprehensive Federal effort relating to early detection of, treatments for, and the prevention of cancer, and for other purposes. 3/29/2007--Introduced. National Cancer Act of 2007 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to establish a loan repayment program for health professionals agreeing to engage in cancer prevention research. Provides for research on cancer treatments that target cancer cells, the cancer care workforce, cancer survivorship, environmental risk factors for cancer, and treatment disparities.Requires the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to carry out demonstration programs on: (1) lung cancer early detection using Computer Tomography (CT) scanning; and (2) colorectal screening.Amends the Federal Food, Drug, and Cosmetic Act to set forth provisions for chemoprevention [...] show full description
Also tagged in: Administrative procedure, Authorization, Budgets, Childbirth, Cytology, Data banks, Department of Health and Human Services, Executive departments, Health information systems, Human embryology, Informed consent (Medical law), Law, Medical care, Medicine, Public contracts, Technology, Transplantation of organs, tissues, etc.
Latest Action: 03/22/2007 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill TextA bill to provide for the collection and maintenance of amniotic fluid and placental stem cells for the treatment of patients and research. 3/22/2007--Introduced. Amniotic Fluid and Placental Stem Cell Banking Act of 2007 - Directs the Secretary of Health and Human Services to enter into one-time contracts with qualified amniotic fluid and placental stem cell banks to assist in the collection and maintenance of 100,000 new units of high-quality amniotic fluid and placental stem cells to be made available for treatment though the C.W. Bill Young Cell Transplantation and Treatment Program. Sets forth provisions relating to requirements for contract recipients, the duration of such contracts, and extensions of funding under such contracts. Amends the Public Health Service Act to revise the Program to provide for amniotic fluid and placental stem cell functions, recruitment, and educational activities. Authorizes appropriations for the Program through FY2012.
Also tagged in: Administrative procedure, Blood tests, Consumers, Data banks, Department of Health and Human Services, Electronic data interchange, Executive departments, Food and Drug Administration (FDA), Genetics, Government information, Government paperwork, Government publicity, Internet, Labeling, Law, Medical care, Medical instruments and apparatus, Medical laboratories, Medical supplies, Medical tests, Medicine, Standards, Technology, Telecommunication, Web sites
Latest Action: 03/01/2007 - Sponsor introductory remarks on measure. (CR S2502-2503) Bill TextA bill to provide for the regulation and oversight of laboratory tests. 3/1/2007--Introduced. Laboratory Test Improvement Act - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to deem a laboratory-developed test that is a direct-to-consumer test to be a prescription test if it satisfies the requirements of this Act. Deems any laboratory-developed test to be a medical device.Sets forth labeling and registration requirements for laboratory-developed tests.Requires the manufacturer of a laboratory-developed test that has not been cleared or approved for its intended use to submit the analytical and clinical validity of the test for its intended use to the Secretary of Health and Human Services. Requires the Secretary to include such information in a public database.Requires the Secretary to provide guidance to: (1) facilitate the use of reviews of the peer-reviewed biomedical literature and other information and data about the clinical validity [...] show full description
Also tagged in: Administrative procedure, Armed forces, Asbestos, Budgets, Business, Cancer, Clinical trials, Consumer education, Consumers, Data banks, Defense policy, Department of Health and Human Services, Environmental health, Environmental protection, Environmental Protection Agency, Environmental research, Executive departments, Federal aid to health facilities, Federal aid to research, Fibers, Government information, Government publicity, Governmental investigations, Hazardous substances, Hazardous wastes, Health education, Health information systems, Import restrictions, Labeling, Labor, Law, Lung cancer, Lung diseases, Manufacturing industries, Medical care, Medical centers, Medical research, Medical screening, Medical tests, Medicine, Military medicine, Minerals, National Institutes of Health (NIH), Occupational health and safety, Pain, Preventive medicine, Product safety, Refuse and refuse disposal, Research centers, Research grants, Science policy, Solid wastes, Technology, Trade, Veterans, Veterans' hospitals, Veterans' medical care
Latest Action: 10/05/2007 - Message on Senate action sent to the House. Bill TextAn act to amend the Toxic Substances Control Act to reduce the health risks posed by asbestos-containing materials and products having asbestos-containing material, and for other purposes. 10/4/2007--Passed Senate amended. (There is 1 other summary) Ban Asbestos in America Act of 2007 - (Sec. 3) Amends the Toxic Substances Control Act to include within the meaning of the term "asbestos" asbestiform varieties of: (1) any material formerly classified as tremolite, including winchite asbestos and richterite asbestos; and (2) any asbestiform amphibole mineral. Requires the Director of the National Institute for Occupational Safety and Health to conduct a study that: (1) describes the science concerning the disease mechanisms and health effects of exposure to non-asbestiform minerals and elongated mineral particles and methods for measuring and analyzing such minerals; and (2) recommends future research relating to diseases caused by exposure [...] show full description
|
